ELI LILLY & Co is 45.9x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($1.070 T vs $23.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | UTHR | LLY |
|---|---|---|
| Market cap | $23.33 B | $1.070 T |
| US-listed rank | #554 | #10 |
| Revenue (latest FY) | $3.18B | $65.18B |
| Net income (latest FY) | $1.33B | $20.64B |
| Net margin | 41.9% | 31.7% |
| P/E (trailing FY) | 17.5 | 51.8 |
| SEC filings | 4,203 | 989 |
ELI LILLY & Co is 45.9x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($1.070 T vs $23.33 B).
In their latest fiscal years, UNITED THERAPEUTICS Corp reported $3.18B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: UNITED THERAPEUTICS Corp and ELI LILLY & Co, or browse the full rankings.